Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DB2F
|
|||
| Former ID |
DIB014699
|
|||
| Drug Name |
Concatameric LAG3Ig
|
|||
| Synonyms |
Concatameric LAG3Ig (immunoadhesin); CD223Ig (immunoadhesin), Medexgen; Concatameric LAG3Ig (immunoadhesin),Medexgen
Click to Show/Hide
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Medexgen Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lymphocyte activation gene 3 protein (LAG3) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study. J Immune Based Ther Vaccines. 2007 Mar 29;5:5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.